Neurorehabilitation Devices Market Size, Share & Forecast Analysis to 2027

Global Neurorehabilitation Devices Market Size, Share, Trends, Industry Growth by Product (Neurorobotic Systems, Brain Computer Interface, Wearable Devices, Non-Invasive Stimulators), by Application, by End-User, by Region, and Forecast to 2027

Report ID: RC88291 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 23rd, 2023

The global neurorehabilitation devices market size is accounted to register a sustainable CAGR of over 15% during the forecast period and is expected to reach over USD 3 billion by 2027. The increasing prevalence of numerous neurological disorders across the globe is a primary factor to drive the market growth. Furthermore, the technological advancement in healthcare and the growing aging population around the world is further anticipated to boost the market growth over the forecast period. it is estimated that around 1%-2% of the world’s population over the age of 60 is estimated to suffer from Parkinson’s disease.

Market Drivers:

Rising Incidence of Neurological Disorders: The increasing prevalence of neurological disorders, such as stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, and multiple sclerosis, is a significant driving factor for the neurorehabilitation devices market. These devices play a crucial role in assisting and facilitating the rehabilitation process for individuals with neurological conditions, improving their functional abilities and quality of life.

Advancements in Technology: Technological advancements have significantly impacted the development of neurorehabilitation devices. Innovations such as robotics, virtual reality, brain-computer interfaces, and neurostimulation techniques have expanded the capabilities and effectiveness of these devices. The integration of advanced technologies into neurorehabilitation devices has led to more personalized, interactive, and efficient rehabilitation interventions.

Growing Aging Population: The global aging population is increasing, leading to a higher prevalence of age-related neurological conditions and disabilities. Neurorehabilitation devices are vital in addressing the specific needs of elderly individuals and promoting their functional recovery. These devices assist in mobility, motor function improvement, cognitive rehabilitation, and daily living activities for the aging population.

Rehabilitation Paradigm Shift: The field of neurorehabilitation has witnessed a paradigm shift from traditional therapy approaches to more evidence-based, task-specific, and technology-driven interventions. Neurorehabilitation devices provide therapists with tools to deliver more precise and targeted rehabilitation, enhancing patient outcomes and accelerating recovery. This shift in rehabilitation approaches has contributed to the demand for neurorehabilitation devices.

Favorable Reimbursement Policies: The availability of favorable reimbursement policies and support from healthcare systems and insurance providers has a significant impact on the adoption of neurorehabilitation devices. Reimbursement for these devices and associated therapy services reduces the financial burden on patients and encourages healthcare facilities to invest in advanced rehabilitation technologies, driving market growth.

Awareness and Demand for Personalized Rehabilitation: Increased awareness among patients, caregivers, and healthcare professionals about the benefits of personalized rehabilitation programs has fueled the demand for neurorehabilitation devices. These devices can be customized to meet individual patient needs and provide tailored rehabilitation interventions, leading to better patient engagement, compliance, and outcomes.

Collaborative Efforts and Research Initiatives: Collaborative efforts between academia, research institutions, and industry players have led to significant advancements in neurorehabilitation device development. Research initiatives focusing on understanding neuroplasticity, neurorecovery mechanisms, and rehabilitation strategies have paved the way for innovative device solutions. Collaborations and investments in research and development activities continue to drive the growth of the neurorehabilitation devices market.

Improved Access to Rehabilitation Services: Efforts to improve access to rehabilitation services, particularly in developing regions, have increased the demand for neurorehabilitation devices. These devices help address the shortage of rehabilitation professionals by providing automated and portable solutions that can be used in community healthcare settings. Improved access to rehabilitation services and devices has a positive impact on patient outcomes and market expansion.

Market Snapshot:

Benchmark Year		2022
Market Size		> USD 3 Billion by 2027
Market Growth (CAGR)		> 15% (2023-2030)
Largest Market Share		North America
Analysis Period		2020-2030
Market Players		Bionik Laboratories Corp., Medtronic plc, Hocoma AG, Ekso Bionics, and Neurostyle Pte Ltd.

Market Insights:

The global neurorehabilitation devices market is bifurcated into product, application, end-user, and geography. On the basis of product, the market is further segmented into neurorobotic systems, brain-computer interfaces, wearable devices, and non-invasive stimulators. The neurorobotic systems segment is accounted to hold the largest revenue share of around one-third percent of the market by the end of the analysis period. Technological advancement and the increasing incidence of neurological disorders are some of the major factors driving the market growth. furthermore, the growth in the geriatric population is further expected to fuel the segment growth over the forecast period.

Neurorehabilitation Devices Market Size & Forecast

To know more about the report, request sample papers

The neurorehabilitation devices comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The neurorehabilitation devices market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Market Segmentation:

By Product:

Neurorobotic Systems
Brain Computer Interface
Wearable Devices
Non-Invasive Stimulators

By Application:

Stroke
Parkinson`s Disease
Brain & Spinal Cord Injury
Cerebral Palsy
Multiple Sclerosis
Others

By End-User:

Rehabilitation Centers
Hospitals & Clinics
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage

Geographically, North America dominated the global neurorehabilitation devices market in 2020 and is expected to grow at similar trends over the forecast period. The strong investment in research and development activities and the presence of well-structured healthcare infrastructure are some major factors to drive the market growth in the region. Furthermore, the rising prevalence of neurological disorders and the increasing investment by major players are further expected to fuel the market growth in North America. Moreover, the technological advancement, increasing adoption of neurorehabilitation devices by hospitals, and growing demand for safe products are expected to propel the market growth in the region.

Competitive Assessment

Some of the major market players operating in the global neurorehabilitation devices market are Bionik Laboratories Corp., Medtronic plc, Hocoma AG, Ekso Bionics, and Neurostyle Pte Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Bionik Laboratories Corp.
Medtronic plc
Hocoma AG
Ekso Bionics
Neurostyle Pte Ltd.
Neuro Device Group S.A.
Saebo, Inc.
Tyromotion GmbH
ReWalk Robotics
Boston Scientific Corporation

Key Questions Answered by Neurorehabilitation Devices Market Report

Global neurorehabilitation devices market forecasts from 2021-2027
Regional neurorehabilitation devices market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the regions as mentioned above
Neurorehabilitation devices submarket forecasts from 2021-2027 covering the market by product, by application, by end-user, and geography
Various industry models such as SWOT analysis, Value Chain Analysis about neurorehabilitation devices market
Analysis of the key factors driving and restraining the growth of the global, regional, and country-level neurorehabilitation devices markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the neurorehabilitation devices market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Neurorehabilitation Devices Market Portraiture
2.2. Global Neurorehabilitation Devices Market, by Product, 2020 (USD Mn)
2.3. Global Neurorehabilitation Devices Market, by Application, 2020 (USD Mn)
2.4. Global Neurorehabilitation Devices Market, by End-User, 2020 (USD Mn)
2.5. Global Neurorehabilitation Devices Market, by Geography, 2020 (USD Mn)

3. Global Neurorehabilitation Devices Market Analysis

3.1. Neurorehabilitation Devices Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis

4. Global Neurorehabilitation Devices Market By Product, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Neurorobotic Systems
4.3. Brain Computer Interface
4.4. Wearable Devices
4.5. Non-Invasive Stimulators

5. Global Neurorehabilitation Devices Market By Application, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Stroke
5.3. Parkinson`s Disease
5.4. Brain & Spinal Cord Injury
5.5. Cerebral Palsy
5.6. Multiple Sclerosis
5.7. Others

6. Global Neurorehabilitation Devices Market By End-User, 2018 – 2027 (USD Mn)

6.1. Overview
6.2. Rehabilitation Centers
6.3. Hospitals & Clinics
6.4. Others

7. North America Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)

7.1.1. Overview
7.1.2. North America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.3. North America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.4. North America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
7.1.5. North America Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.5.1.2. U.S. Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.5.1.3. U.S. Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.5.2.2. Canada Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.5.2.3. Canada Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)

8. Europe Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. Europe Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.3. Europe Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.4. Europe Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5. Europe Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.1.2. Germany Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.1.3. Germany Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.2.2. U.K. Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.2.3. U.K. Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.3.2. France Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.3.3. France Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.4.2. Italy Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.4.3. Italy Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)

9. Asia Pacific Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Asia Pacific Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.3. Asia Pacific Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.4. Asia Pacific Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5. Asia Pacific Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.1.2. China Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.1.3. China Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.2.2. Japan Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.2.3. Japan Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)

10. Latin America (LATAM) Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. Latin America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.3. Latin America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.4. Latin America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5. Latin America Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.1.2. Brazil Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.1.3. Brazil Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.2.2. Mexico Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.2.3. Mexico Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)

11. Middle East and Africa Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)

11.1.1. Overview
11.1.2. MEA Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.3. MEA Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.4. MEA Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5. Middle East and Africa Neurorehabilitation Devices Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.1.2. GCC Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.1.3. GCC Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.2.2. South Africa Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.2.3. South Africa Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)

12. Company Profiles

12.1. Bionik Laboratories Corp.
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Medtronic plc
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Hocoma AG
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. Ekso Bionics
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Neurostyle Pte Ltd.
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Neuro Device Group S.A.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Saebo, Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Tyromotion GmbH
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. ReWalk Robotics
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Boston Scientific Corporation
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis

Fill the given form to inquiry before buying for Global Neurorehabilitation Devices Market Size, Share, Trends, Industry Growth by Product (Neurorobotic Systems, Brain Computer Interface, Wearable Devices, Non-Invasive Stimulators), by Application, by End-User, by Region, and Forecast to 2027 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 5200/- Multi User License
$ 6995/- Corporate License

For Any Assitance

Email: sales@researchcorridor.com